Bacteriophage start-up secures €21 million
Proteon Pharmaceuticals, a company that specializes in developing bacteriophage therapies for the livestock sector, has secured a €21 million investment to accelerate the commercialization of its products.© Dr Subhashini
© Dr Subhashini

